Catheter ablation of pulmonary veins is one of the most widely used techniques in interventional cardiology.1 The technique requires patient immobility and the anesthetic approach usually uses intravenous perfusions of propofol and remifentanil, which have proven to be suitable drugs in this scenario, as they do not significantly interfere with the electrophysiological function of the atrial-ventricular node.2,3 To ensure proper depth of anesthesia during the procedure, the bispectral index (BIS) for hypnotic depth is monitored.4
It is well known that there is an inversely proportional relationship between cardiac output and plasma concentrations of propofol.5,6 This relationship implies that any increase in cardiac output during the maintenance of anesthesia may lower the concentrations of the anesthetic drugs, exposing the patient to a risk of intraoperative awareness. This complication during general anesthesia may result in chronic mental repercussions for the patient,7 but may also involve mechanical complications during the procedure when muscle relaxants are not used and the patient moves while a precise technique is being performed.
This paper discusses a case of sudden awareness following isoproterenol infusion, which illustrates how the relationship between cardiac output and drug concentrations may influence the doses required for maintaining the levels of propofol and remifentanil.
This is a 50-year-old female patient with 67 kg of body weight who was admitted for radiofrequency ablation of persistent focal atrial tachycardia originating in the left atrium. A right femoral vein approach was used for a transseptal puncture with SLO (vaina Swartz Braided Transseptal St Jude Medical serie SL0 63 cm.) sheath and BRK-1 XS needle to access the left atrium. Through electroanatomical mapping using the Ensite Precision navigation system and a contact force ablation catheter (SJM TactiCath), a left atrial activation map was developed, documenting the origin of the atrial tachycardia in the antrum of the upper left pulmonary vein. Using power and temperature control (40 W—42°), several radiofrequency applications were administered until successful ablation of the atrial tachycardia. The procedure was carried out with the patient anti-coagulated with non-fractionated heparin.
The intervention was conducted under general anesthesia. The patient was pre-medicated with 2 milligrams (mg) of midazolam and the induction was performed with 200 μg of fentanyl, 50 mg of propofol, and 50 mg of rocuronium, for subsequent endotracheal intubation with a Rusch tube. Then, the objective of maintaining the anesthesia was to maintain hypnotic depth BIS values of around 60, which was initially accomplished with low-dose propofol perfusions (1.2 mg/kg/hour) and remifentanil (0.08 μg/kg/minute), and additional boluses of rocuronium to ensure the patient's immobility during ablation.
The hemodynamic monitoring showed in the electrocardiogram a basal tachyarrhythmia of over 200 bpm, whereas the non-invasive blood pressure monitor was unable to elicit any readings; this issue had been previously reported by the patient. Following the catheterization of the left radial artery, the invasive arterial pressure reading showed quite oscillating values, with maximum readings of 90/50 mm Hg, and a heart rate measured with pulse pressure wave of merely 30–45 bpm.
The hemodynamic situation improved gradually, as the elimination of ectopic foci progressed, obtaining progressively higher blood pressure readings. Simultaneously, to maintain the BIS values around 60, it was necessary to increase the propofol and remifentanil infusion rates (up to 3 mg/kg/hour and up to 0.14 μg/kg/minute, respectively). The hemodynamic situation totally normalized after the ablation (electric and mechanical frequencies were both 61 bpm, the systolic blood pressures stabilized around 100 mm Hg). Over more than 2 hours since the start of the procedure, the BIS was stable at around 60.
To check the efficacy of the ablation, an isoproterenol perfusion was initiated up to 4 μg/minute, resulting in a rapid heart rate increase from 61 to 144 bpm, with a mild drop in the systolic blood pressure to 85 mm Hg which was treated with a 50-μg bolus of phenylephrine. At this moment, the anesthetic infusions were maintained at a stable level. After approximately 3 to 4 minutes of the onset of tachycardia, and with no apparent external stimulus, the patient suddenly stood up from the procedure table with a subsequent abrupt increase in the electrical and muscular BIS values. The immediate administration of boluses of propofol, midazolam, and rocuronium was able to bring the situation under control. Following this episode, the heart rate returned to 61 bpm, but to restabilize the depth of anesthesia at around 60, the perfusion doses of propofol, and remifentanil had to be raised (4.5 mg/kg/hour and 0.18 μg/kg/minute, respectively). At the end of the study, 1 hour later, the patient emerged swiftly with no memories of the incident.
The case herein discussed exemplifies how the isoproterenol infusion may bring about intraoperative awareness. This complication has been previously described in similar procedures, although in those cases the patients were under sedation when the isoproterenol was infused.8–10 However, the infusion of this drug has not been considered an independent risk factor in the various reviews conducted on the causes of intraoperative awareness.4 In this case, the decision was made to administer general anesthesia based on the protocol adopted at our institution, and a total intravenous anesthesia was administered, notwithstanding the hemodynamic instability of the patient, because of 2 reasons: one strictly pharmacological (the null effect of remifentanil2 and propofol3 on the electrophysiological function of the atrioventricular node), and the other due to occupational health considerations (the arrhythmia room does not have a system for venting anesthetic gases).
In our opinion, there are 2 probable explanations for this phenomenon of intraoperative awareness. One of the theories that has been postulated is that awareness is the result of the modulation of consciousness at the central level, secondary to isoproterenol-induced stimulation of the adrenergic system.8,9 On the other hand, as previously stated, there is an inverse relationship between cardiac output and the concentration of propofol. Some papers have objectively concluded that the concentration of propofol during continuous infusion is inversely proportional to the increase in cardiac output, both in animals6,11 and in humans, following the administration of dopamine12 or atropine.13 In fact, it has been established that the exogenous infusion of drugs that cause hyperdynamic circulation, including isoproterenol,8,9 adrenaline,14,15 or ephedrine,16 have an awareness effect or a significant increase of BIS in patients undergoing procedures under sedation. In contrast, the infusion of beta blockers has shown to reduce the requirements of intravenous anesthetic agents such as propofol.17
In our opinion, the second explanation is more consistent with our case, because it could explain both the abrupt episode of intraoperative awareness with isoprenaline due to the sudden drop in the concentrations of propofol, and the continuous increase in the doses of propofol needed to maintain a BIS value of around 60.
In fact, during the maintenance of anesthesia, the doses of propofol required to stabilize the BIS level were lower at basal conditions of disorganized cardiac contraction than the doses needed to maintain that same effect upon eliminating the ectopic foci. We don’t have any cardiac output or propofol concentration measurements available, but we assume that the gradual normalization of the cardiac contraction progressively increased the stroke volume and hence the cardiac output, reducing the concentration of propofol, and hence requiring a propofol dose increase. This same reasoning could explain how, upon an abrupt increase in cardiac output with the administration of isoproterenol and phenylephrine, the patient presented with a sudden intraoperative awareness episode. However, the effect of the drugs that increase the cardiac output has already been measured in animals,5,6 so it would be feasible with the necessary resources to undertake similar trials in humans, measuring the propofol concentrations pre and postisoproterenol infusion.
In summary, as a general rule, the recommendation is to adapt the anesthetic requirements to the patient's hemodynamic condition, both in terms of the baseline level, as well as with regards to any alterations that may develop. Our specific recommendation is to evaluate the possibility of administering a bolus of anesthetic agent before the administration of isoproterenol during ablation of pulmonary veins.
Informed Consent. The patient submitted her informed consent to publish this case report.
Protection of persons and animals. The authors declare that no experiments in humans or animals were conducted for this research paper.
Confidentiality of the information. The authors declare that no patient data are disclosed in this article.
Right to privacy and informed consent. The authors declare that no patient data are disclosed in this article.
No funding or production agency participated in this publication.
Conflicts of interest
The authors have no conflict of interests to disclose.
1. Di Biase L, Conti S, Mohanty P, et al. General anesthesia reduces the prevalence of pulmonary vein reconnection during repeat ablation when compared with conscious sedation: results from a randomized study. Heart Rhythm
2. Fattorini F, Romano R, Ciccaglioni A, et al. Effects of remifentanil on human heart electrical system. A transesophageal pacing electrophysiological study. Minerva Anestesiol
3. Warpechowski P, Lima GG, Medeiros CM, et al. Randomized study of propofol
effect on electrophysiological properties of the atrioventricular node in patients with nodal reentrant tachycardia. Pacing Clin Electrophysiol
4. Castellon-Larios K, Rosero B, Niño-de Mejía M, et al. The use of cerebral monitoring for intraoperative awareness
. Rev Colomb Anestesiol
5. Upton RN, Ludbrook GL, Grant C, et al. Cardiac output is a determinant of the initial concentrations of propofol
after short-infusion administration. Anesth Analg
6. Myburgh JA, Upton RN, Grant C, et al. Epinephrine, norepinephrine and dopamine infusions decrease propofol
concentrations during continuous propofol
infusion in an ovine model. Intensive Care Med
7. Ghoneim MM. Awareness during anesthesia. Anesthesiology
8. O’Neill DK, Aizer A, Linton P, et al. Isoproterenol
infusion increases level of consciousness during catheter ablation
of atrial fibrillation. J Interv Card Electrophysiol
9. Matthews R. Isoproterenol
-induced elevated bispectral indexes while undergoing radiofrequency ablation: a case report. AANA J
10. Johnson IA, Andrzejowski J, Sikiotis L. Arousal following isoprenaline. Anaesth Intensive Care
11. Kurita T, Morita K, Kazama T, et al. Influence of cardiac output on plasma propofol
concentrations during constant infusion in swine. Anesthesiology
12. Takizawa D, Nishikawa K, Sato E, et al. A dopamine infusion decreases propofol
concentration during epidural blockade under general anesthesia. Can J Anaesth
13. Takizawa E, Takizawa D, Al-Jahdari WS, et al. Influence of atropine on the dose requirements of propofol
in humans. Drug Metab Pharmacokinet
14. Shin HW, Ban YJ, Lee HW, et al. Arousal with IV epinephrine depends on the depth of anesthesia. Can J Anaesth
15. Andrzejowski J, Sleigh JW, Johnson IA, et al. The effect of intravenous epinephrine on the bispectral index and sedation. Anaesthesia
16. Ishiyama T, Oguchi T, Iijima T, et al. Ephedrine, but not phenylephrine, increases bispectral index values during combined general and epidural anesthesia. Anesth Analg
17. Ghosh I, Bithal PK, Dash HH, et al. Both clonidine and metoprolol modify anesthetic depth indicators and reduce intraoperative propofol
requirement. J Anesth